Biotech and Pharmaceuticals
June 8th, 2024FDA approves GSK RSV vaccine for adults 50 to 59 – MASHAHER
- June 3rd, 2024
Moderna, Merck cancer vaccine with Keytruda improved survival in trial – MASHAHER
- May 31st, 2024
FDA approves Moderna RSV vaccine for seniors – MASHAHER
- May 25th, 2024
FDA panel votes against Novo Nordisk’s weekly insulin in type 1 diabetes patients – MASHAHER
- May 24th, 2024
What to know about human cases, vaccines – MASHAHER
- May 18th, 2024
Study links talc to ovarian cancer, with implications for J&J – MASHAHER
- May 16th, 2024
FDA approves Amgen small cell lung cancer treatment – MASHAHER
- May 14th, 2024
Wegovy patients maintain weight loss for 4 years: Novo Nordisk study – MASHAHER
- May 14th, 2024
OpenAI is first company to be No. 1 on Disruptor 50 two years in a row – MASHAHER
- May 10th, 2024
Novavax and Sanofi to commercialize Covid vaccine, develop combo shots – MASHAHER
- May 7th, 2024
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance – MASHAHER
- May 2nd, 2024
Moderna (MRNA ) earnings Q1 2024 – MASHAHER
No more posts
No more posts